Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Neuropsychology Review
Published in: Neuropsychology Review 2/2013

01-06-2013 | Review

Effects of Cannabis on Neurocognitive Functioning: Recent Advances, Neurodevelopmental Influences, and Sex Differences

Authors: Natania A. Crane, Randi Melissa Schuster, Paolo Fusar-Poli, Raul Gonzalez

Published in: Neuropsychology Review | Issue 2/2013

Login to get access

Abstract

Decades of research have examined the effects of cannabis on neurocognition. Recent advances in this field provide us with a better understanding of how cannabis use influences neurocognition both acutely (during intoxication) and non-acutely (after acute effects subside). Evidence of problems with episodic memory is one of the most consistent findings reported; however, several other neurocognitive domains appear to be adversely affected by cannabis use under various conditions. There is significant variability in findings across studies, thus a discussion of potential moderators is increasingly relevant. The purpose of this review was to 1) provide an update on research of cannabis’ acute and non-acute effects on neurocognition, with a focus on findings since 2007 and 2) suggest and discuss how neurodevelopmental issues and sex differences may influence cannabis effects on neurocognition. Finally we discuss how future investigations may lead to better understanding of the complex interplay among cannabis, stages of neurodevelopment, and sex on neurocognitive functioning.
Literature
Abdullaev, Y., Posner, M. I., Nunnally, R., & Dishion, T. J. (2010). Functional MRI evidence for inefficient attentional control in adolescent chronic cannabis abuse. Behavioural Brain Research, 215(1), 45–57.PubMedCrossRef
Abush, H., & Akirav, I. (2012). Short- and long-term cognitive effects of chronic cannabinoids administration in late-adolescence rats. PLoS One, 7(2), e31731.PubMedCrossRef
Aharonovich, E., Brooks, A. C., Nunes, E. V., & Hasin, D. S. (2008). Cognitive deficits in marijuana users: effects on motivational enhancement therapy plus cognitive behavioral therapy treatment outcome. Drug and Alcohol Dependence, 95(3), 279–283.PubMedCrossRef
Anderson, B. M., Rizzo, M., Block, R. I., Pearlson, G. D., & O’Leary, D. S. (2010). Sex, drugs, and cognition: effects of marijuana. Journal of Psychoactive Drugs, 42(4), 413–424.PubMedCrossRef
Asbridge, M., Hayden, J. A., & Cartwright, J. L. (2012). Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ, 344, e536.PubMedCrossRef
Ballard, M. E., Gallo, D. A., & de Wit, H. (2012). Psychoactive drugs and false memory: comparison of dextroamphetamine and delta-9-tetrahydrocannabinol on false recognition. Psychopharmacology, 219(1), 15–24.PubMedCrossRef
Battisti, R. A., Roodenrys, S., Johnstone, S. J., Pesa, N., Hermens, D. F., & Solowij, N. (2010). Chronic cannabis users show altered neurophysiological functioning on Stroop task conflict resolution. Psychopharmacology, 212(4), 613–624.PubMedCrossRef
Battisti, R. A., Roodenrys, S., Johnstone, S. J., Respondek, C., Hermens, D. F., & Solowij, N. (2010). Chronic use of cannabis and poor neural efficiency in verbal memory ability. Psychopharmacology, 209(4), 319–330.PubMedCrossRef
Bava, S., & Tapert, S. F. (2010). Adolescent brain development and the risk for alcohol and other drug problems. Neuropsychology Review, 20(4), 398–413.PubMedCrossRef
Bechara, A. (2005). Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nature Neuroscience, 8(11), 1458–1463.PubMedCrossRef
Becker, B., Wagner, D., Gouzoulis-Mayfrank, E., Spuentrup, E., & Daumann, J. (2010). The impact of early-onset cannabis use on functional brain correlates of working memory. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 34(6), 837–845.CrossRef
Bhattacharyya, S., Fusar-Poli, P., Borgwardt, S., Martin-Santos, R., Nosarti, C., O’Carroll, C., et al. (2009). Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Archives of General Psychiatry, 66(4), 442–451.PubMedCrossRef
Bhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Winton-Brown, T., et al. (2010). Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology, 35(3), 764–774.PubMedCrossRef
Bhattacharyya, S., Crippa, J. A., Allen, P., Martin-Santos, R., Borgwardt, S., Fusar-Poli, P., et al. (2012). Induction of psychosis by Delta9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing. Archives of General Psychiatry, 69(1), 27–36.PubMedCrossRef
Boggio, P. S., Zaghi, S., Villani, A. B., Fecteau, S., Pascual-Leone, A., & Fregni, F. (2010). Modulation of risk-taking in marijuana users by transcranial direct current stimulation (tDCS) of the dorsolateral prefrontal cortex (DLPFC). Drug and Alcohol Dependence, 112(3), 220–225.PubMedCrossRef
Bolla, K. I., Eldreth, D. A., Matochik, J. A., & Cadet, J. L. (2004). Sex-related differences in a gambling task and its neurological correlates. Cerebral Cortex, 14(11), 1226–1232.PubMedCrossRef
Bolla, K. I., Eldreth, D. A., Matochik, J. A., & Cadet, J. L. (2005). Neural substrates of faulty decision-making in abstinent marijuana users. NeuroImage, 26(2), 480–492.PubMedCrossRef
Borgwardt, S. J., Allen, P., Bhattacharyya, S., Fusar-Poli, P., Crippa, J. A., Seal, M. L., et al. (2008). Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition. Biological Psychiatry, 64(11), 966–973.PubMedCrossRef
Bossong, M. G., Jager, G., van Hell, H. H., Zuurman, L., Jansma, J. M., Mehta, M. A., et al. (2012). Effects of Delta9-tetrahydrocannabinol administration on human encoding and recall memory function: a pharmacological FMRI study. Journal of Cognitive Neuroscience, 24(3), 588–599.PubMedCrossRef
Bossong, M. G., Jansma, J. M., van Hell, H. H., Jager, G., Oudman, E., Saliasi, E., et al. (2012). Effects of delta9-tetrahydrocannabinol on human working memory function. Biological Psychiatry, 71(8), 693–699.
Bradshaw, H. B., Rimmerman, N., Krey, J. F., & Walker, J. M. (2006). Sex and hormonal cycle differences in rat brain levels of pain-related cannabimimetic lipid mediators. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, 291(2), R349–R358.PubMedCrossRef
Burgdorf, J. R., Kilmer, B., & Pacula, R. L. (2011). Heterogeneity in the composition of marijuana seized in California. Drug and Alcohol Dependence, 117(1), 59–61.PubMedCrossRef
Burston, J. J., Wiley, J. L., Craig, A. A., Selley, D. E., & Sim-Selley, L. J. (2010). Regional enhancement of cannabinoid CB1 receptor desensitization in female adolescent rats following repeated Delta-tetrahydrocannabinol exposure. British Journal of Pharmacology, 161(1), 103–112.PubMedCrossRef
Busemeyer, J. R., & Stout, J. C. (2002). A contribution of cognitive decision models to clinical assessment: decomposing performance on the Bechara gambling task. Psychological Assessment, 14(3), 253–262.PubMedCrossRef
Cane, J. E., Sharma, D., & Albery, I. P. (2009). The addiction Stroop task: examining the fast and slow effects of smoking and marijuana-related cues. Journal of Psychopharmacology, 23(5), 510–519.PubMedCrossRef
Cha, Y. M., Jones, K. H., Kuhn, C. M., Wilson, W. A., & Swartzwelder, H. S. (2007). Sex differences in the effects of delta9-tetrahydrocannabinol on spatial learning in adolescent and adult rats. Behavioural Pharmacology, 18(5–6), 563–569.PubMedCrossRef
Chang, L., Yakupov, R., Cloak, C., & Ernst, T. (2006). Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation. Brain, 129(Pt 5), 1096–1112.PubMedCrossRef
Clark, L., Cools, R., & Robbins, T. W. (2004). The neuropsychology of ventral prefrontal cortex: decision-making and reversal learning. Brain and Cognition, 55(1), 41–53.PubMedCrossRef
Clark, L., Roiser, J. P., Robbins, T. W., & Sahakian, B. J. (2009). Disrupted ‘reflection’ impulsivity in cannabis users but not current or former ecstasy users. Journal of Psychopharmacology, 23(1), 14–22.PubMedCrossRef
Cocchetto, D. M., Owens, S. M., Perez-Reyes, M., DiGuiseppi, S., & Miller, L. L. (1981). Relationship between plasma delta-9-tetrahydrocannabinol concentration and pharmacologic effects in man. Psychopharmacology, 75(2), 158–164.PubMedCrossRef
Cohen, P. J. (2010). Medical marijuana 2010: it’s time to fix the regulatory vacuum. The Journal of Law, Medicine & Ethics, 38(3), 654–666.CrossRef
Compton, W. M., Grant, B. F., Colliver, J. D., Glantz, M. D., & Stinson, F. S. (2004). Prevalence of marijuana use disorders in the United States: 1991–1992 and 2001–2002. Journal of the American Medical Association, 291(17), 2114–2121.PubMedCrossRef
Crean, R. D., Crane, N. A., & Mason, B. J. (2011). An evidence based review of acute and long-term effects of cannabis Use on executive cognitive functions. Journal of Addiction Medicine, 5(1), 1–8.PubMedCrossRef
Crippa, J. A., Zuardi, A. W., Martin-Santos, R., Bhattacharyya, S., Atakan, Z., McGuire, P., et al. (2009). Cannabis and anxiety: a critical review of the evidence. Human Psychopharmacology, 24(7), 515–523.PubMedCrossRef
Crippa, J. A., Derenusson, G. N., Ferrari, T. B., Wichert-Ana, L., Duran, F. L., Martin-Santos, R., et al. (2011). Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. Journal of Psychopharmacology, 25(1), 121–130.PubMedCrossRef
Cunha, P. J., Nicastri, S., de Andrade, A. G., & Bolla, K. I. (2010). The frontal assessment battery (FAB) reveals neurocognitive dysfunction in substance-dependent individuals in distinct executive domains: abstract reasoning, motor programming, and cognitive flexibility. Addictive Behaviors, 35(10), 875–881.PubMedCrossRef
de Wit, H. (2009). Impulsivity as a determinant and consequence of drug use: a review of underlying processes. Addiction Biology, 14(1), 22–31.PubMedCrossRef
Drummer, O. H., Gerostamoulos, J., Batziris, H., Chu, M., Caplehorn, J. R., Robertson, M. D., et al. (2003). The incidence of drugs in drivers killed in Australian road traffic crashes. Forensic Science International, 134(2–3), 154–162.PubMedCrossRef
D’Souza, D. C., Braley, G., Blaise, R., Vendetti, M., Oliver, S., Pittman, B., et al. (2008). Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans. Psychopharmacology, 198(4), 587–603.PubMedCrossRef
D’Souza, D. C., Ranganathan, M., Braley, G., Gueorguieva, R., Zimolo, Z., Cooper, T., et al. (2008). Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis. Neuropsychopharmacology, 33(10), 2505–2516.PubMedCrossRef
Dumont, G. J., van Hasselt, J. G., de Kam, M., van Gerven, J. M., Touw, D. J., Buitelaar, J. K., et al. (2011). Acute psychomotor, memory and subjective effects of MDMA and THC co-administration over time in healthy volunteers. Journal of Psychopharmacology, 25(4), 478–489.PubMedCrossRef
Durston, S., Hulshoff Pol, H. E., Casey, B. J., Giedd, J. N., Buitelaar, J. K., & van Engeland, H. (2001). Anatomical MRI of the developing human brain: what have we learned? Journal of the American Academy of Child and Adolescent Psychiatry, 40(9), 1012–1020.PubMedCrossRef
Ehrenreich, H., Rinn, T., Kunert, H. J., Moeller, M. R., Poser, W., Schilling, L., et al. (1999). Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology, 142(3), 295–301.PubMedCrossRef
Elikkottil, J., Gupta, P., & Gupta, K. (2009). The analgesic potential of cannabinoids. Journal of Opioid Management, 5(6), 341–357.PubMed
Ellis, R. J., Toperoff, W., Vaida, F., van den Brande, G., Gonzales, J., Gouaux, B., et al. (2009). Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology, 34(3), 672–680.PubMedCrossRef
Elsohly, M. A., & Slade, D. (2005). Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sciences, 78(5), 539–548.PubMedCrossRef
Fairfield, K. M., Eisenberg, D. M., Davis, R. B., Libman, H., & Phillips, R. S. (1998). Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Archives of Internal Medicine, 158(20), 2257–2264.PubMedCrossRef
Fattore, L., Spano, M. S., Altea, S., Angius, F., Fadda, P., & Fratta, W. (2007). Cannabinoid self-administration in rats: sex differences and the influence of ovarian function. British Journal of Pharmacology, 152(5), 795–804.PubMedCrossRef
Fernandez-Serrano, M. J., Perez-Garcia, M., Schmidt Rio-Valle, J., & Verdejo-Garcia, A. (2010). Neuropsychological consequences of alcohol and drug abuse on different components of executive functions. Journal of Psychopharmacology, 24(9), 1317–1332.PubMedCrossRef
Fernandez-Serrano, M. J., Perez-Garcia, M., & Verdejo-Garcia, A. (2011). What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance? Neuroscience and Biobehavioral Reviews, 35(3), 377–406.PubMedCrossRef
Ferraro, D. P. (1980). Acute effects of marijuana on human memory and cognition. NIDA Research Monograph, 31, 98–119.PubMed
Fisk, J. E., & Montgomery, C. (2008). Real-world memory and executive processes in cannabis users and non-users. Journal of Psychopharmacology, 22(7), 727–736.PubMedCrossRef
Fontes, M. A., Bolla, K. I., Cunha, P. J., Almeida, P. P., Jungerman, F., Laranjeira, R. R., et al. (2011a). Cannabis use before age 15 and subsequent executive functioning. The British Journal of Psychiatry, 198(6), 442–447.PubMedCrossRef
Fontes, M. A., Bolla, K. I., Cunha, P. J., Almeida, P. P., Jungerman, F., Laranjeira, R. R., et al. (2011b). Frontal Assessment Battery (FAB) is a simple tool for detecting executive deficits in chronic cannabis users. Journal of Clinical and Experimental Neuropsychology, 33(5), 523–531.PubMedCrossRef
Fridberg, D. J., Queller, S., Ahn, W. Y., Kim, W., Bishara, A. J., Busemeyer, J. R., et al. (2010). Cognitive mechanisms underlying risky decision-making in chronic cannabis users. Journal of Mathematical Psychology, 54(1), 28–38.PubMedCrossRef
Fusar-Poli, P., & Meyer-Lindenberg, A. (2012a). Striatal presynaptic dopamine in schizophrenia, Part I: meta-analysis of dopamine active transporter (DAT) density. Schizophrenia Bulletin. doi:10.​1093/​schbul/​sbr111.
Fusar-Poli, P., & Meyer-Lindenberg, A. (2012b). Striatal presynaptic dopamine in schizophrenia, Part II: meta-analysis of [18F/11C]-DOPA PET studies. Schizophrenia Bulletin. doi:10.​1093/​schbul/​sbr180.
Fusar-Poli, P., Crippa, J. A., Bhattacharyya, S., Borgwardt, S. J., Allen, P., Martin-Santos, R., et al. (2009). Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Archives of General Psychiatry, 66(1), 95–105.PubMedCrossRef
Fusar-Poli, P., Allen, P., Bhattacharyya, S., Crippa, J. A., Mechelli, A., Borgwardt, S., et al. (2010a). Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiol. The International Journal of Neuropsychopharmacology, 13(4), 421–432.PubMedCrossRef
Fusar-Poli, P., Howes, O. D., Allen, P., Broome, M., Valli, I., Asselin, M. C., et al. (2010b). Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study. Archives of General Psychiatry, 67(7), 683–691.PubMedCrossRef
Fusar-Poli, P., Borgwardt, S., Crescini, A., Deste, G., Kempton, M. J., Lawrie, S., et al. (2011a). Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neuroscience and Biobehavioral Reviews, 35(5), 1175–1185.PubMedCrossRef
Fusar-Poli, P., Howes, O. D., Allen, P., Broome, M., Valli, I., Asselin, M. C., et al. (2011b). Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis. Molecular Psychiatry, 16(1), 67–75.PubMedCrossRef
Fusar-Poli, P., Radua, J., McGuire, P., & Borgwardt, S. (2011c). Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies. Schizophrenia Bulletin. doi:10.​1093/​schbul/​sbr134.
Fusar-Poli, P., Stone, J. M., Broome, M. R., Valli, I., Mechelli, A., McLean, M. A., et al. (2011d). Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis. Archives of General Psychiatry, 68(9), 881–890.PubMedCrossRef
Fusar-Poli, P., Bechdolf, A., Taylor, M. J., Bonoldi, I., Carpenter, W. T., Yung, A. R., et al. (2012). At risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical risk. Schizophrenia Bulletin. doi:10.​1093/​schbul/​sbs060.
Fusar-Poli, P., Borgwardt, S., Bechdolf, A., Addington, J., Riecher-Rössler, A., Schultze-Lutter, F., et al. (in press). The psychosis high risk state: a comprehensive state of the art review. Archives of General Psychiatry.
Gfroerer, J. C., & Epstein, J. F. (1999). Marijuana initiates and their impact on future drug abuse treatment need. Drug and Alcohol Dependence, 54(3), 229–237.PubMedCrossRef
Giedd, J. N. (2004). Structural magnetic resonance imaging of the adolescent brain. Annals of the New York Academy of Sciences, 1021, 77–85.PubMedCrossRef
Giedd, J. N., Blumenthal, J., Jeffries, N. O., Castellanos, F. X., Liu, H., Zijdenbos, A., et al. (1999). Brain development during childhood and adolescence: a longitudinal MRI study. Nature Neuroscience, 2(10), 861–863.PubMedCrossRef
Gogtay, N., Giedd, J. N., Lusk, L., Hayashi, K. M., Greenstein, D., Vaituzis, A. C., et al. (2004). Dynamic mapping of human cortical development during childhood through early adulthood. Proceedings of the National Academy of Sciences of the United States of America, 101(21), 8174–8179.PubMedCrossRef
Goldstein, R. Z., & Volkow, N. D. (2002). Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. The American Journal of Psychiatry, 159(10), 1642–1652.PubMedCrossRef
Gonzalez, R. (2007). Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance. Neuropsychology Review, 17(3), 347–361.PubMedCrossRef
Gonzalez, S., Mauriello-Romanazzi, G., Berrendero, F., Ramos, J. A., Franzoni, M. F., & Fernandez-Ruiz, J. (2000). Decreased cannabinoid CB1 receptor mRNA levels and immunoreactivity in pituitary hyperplasia induced by prolonged exposure to estrogens. Pituitary, 3(4), 221–226.PubMedCrossRef
Gonzalez, R., Carey, C., & Grant, I. (2002). Nonacute (residual) neuropsychological effects of cannabis use: a qualitative analysis and systematic review. Journal of Clinical Pharmacology, 42(11 Suppl), 48S–57S.PubMed
Gonzalez, R., Rippeth, J. D., Carey, C. L., Heaton, R. K., Moore, D. J., Schweinsburg, B. C., et al. (2004). Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure. Drug and Alcohol Dependence, 76(2), 181–190.PubMedCrossRef
Gonzalez, R., Bechara, A., & Martin, E. M. (2007). Executive functions among individuals with methamphetamine or alcohol as drugs of choice: preliminary observations. Journal of Clinical and Experimental Neuropsychology, 29(2), 155–159.PubMedCrossRef
Gonzalez, R., Vassileva, J., & Scott, J. C. (2009). Neuropsychological consequences of drug abuse. In I. Grant & K. M. Adams (Eds.), Neuropsychological Assessment of Neuropsychiatric Disorders (3rd ed., pp. 455–479). New York: Oxford University Press.
Gonzalez, R., Schuster, R. M., Vassileva, J., & Martin, E. M. (2011). Impact of HIV and a history of marijuana dependence on procedural learning among individuals with a history of substance dependence. Journal of Clinical and Experimental Neuropsychology, 33(7), 735–752.PubMedCrossRef
Gonzalez, R., Schuster, R.M., Crane, N.A., Martin, E.M., Vassileva, J. (2012). Decision-Making Performance Influences the Relationship between Amount of Cannabis use and its Negative Consequences. Journal of the International Neuropsychological Society, 18. doi:10.​1017/​S135561771200054​9.
Gonzalez, R., Schuster, R. M., Mermelstein, R. J., Vassileva, J., Martin, E. M., & Diviak, K. R. (2012). Performance of young adult cannabis users on neurocognitive measures of impulsive behavior and their relationships to symptoms of cannabis use disorders. Journal of Clinical and Experimental Neuropsychology. doi:10.​1080/​13803395.​2012.​703642
Gorzalka, B. B., Hill, M. N., & Hillard, C. J. (2008). Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders. Neuroscience and Biobehavioral Reviews, 32(6), 1152–1160.PubMedCrossRef
Grant, I., Gonzalez, R., Carey, C. L., Natarajan, L., & Wolfson, T. (2003). Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study. Journal of the International Neuropsychological Society, 9(5), 679–689.PubMedCrossRef
Grant, J. E., Chamberlain, S. R., Schreiber, L., & Odlaug, B. L. (2011). Neuropsychological deficits associated with cannabis use in young adults. Drug and Alcohol Dependence, 121(1-2), 159–162.
Gruber, S. A., Sagar, K. A., Dahlgren, M. K., Racine, M., & Lukas, S. E. (2012). Age of onset of marijuana use and executive function. Psychology of Addictive Behaviors, 26(3), 496–506.
Gruber, S. A., Dahlgren, M. K., Sagar, K. A., Gonenc, A., & Killgore, W. D. (2012). Age of onset of marijuana use impacts inhibitory processing. Neuroscience Letters, 511(2), 89–94.PubMedCrossRef
Gur, R. C., Richard, J., Calkins, M. E., Chiavacci, R., Hansen, J. A., Bilker, W. B., et al. (2012). Age group and sex differences in performance on a computerized neurocognitive battery in children age 8–21. Neuropsychology, 26(2), 251–265.PubMedCrossRef
Hadjiefthyvoulou, F., Fisk, J. E., Montgomery, C., & Bridges, N. (2011). Prospective memory functioning among ecstasy/polydrug users: evidence from the Cambridge Prospective Memory Test (CAMPROMPT). Psychopharmacology, 215(4), 761–774.PubMedCrossRef
Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998). Cannabidiol and (−)Delta9-tetrahydrocannabinol are neuroprotective antioxidants. Proceedings of the National Academy of Sciences of the United States of America, 95(14), 8268–8273.PubMedCrossRef
Hanson, K. L., Winward, J. L., Schweinsburg, A. D., Medina, K. L., Brown, S. A., & Tapert, S. F. (2010). Longitudinal study of cognition among adolescent marijuana users over three weeks of abstinence. Addictive Behaviors, 35(11), 970–976.PubMedCrossRef
Hart, C. L., Ilan, A. B., Gevins, A., Gunderson, E. W., Role, K., Colley, J., et al. (2010). Neurophysiological and cognitive effects of smoked marijuana in frequent users. Pharmacology, Biochemistry, and Behavior, 96(3), 333–341.PubMedCrossRef
Harte, L. C., & Dow-Edwards, D. (2010). Sexually dimorphic alterations in locomotion and reversal learning after adolescent tetrahydrocannabinol exposure in the rat. Neurotoxicology and Teratology, 32(5), 515–524.PubMedCrossRef
Harvey, M. A., Sellman, J. D., Porter, R. J., & Frampton, C. M. (2007). The relationship between non-acute adolescent cannabis use and cognition. Drug and Alcohol Review, 26(3), 309–319.PubMedCrossRef
Hermann, D., Sartorius, A., Welzel, H., Walter, S., Skopp, G., Ende, G., et al. (2007). Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis users. Biological Psychiatry, 61(11), 1281–1289.PubMedCrossRef
Hermann, D., Lemenager, T., Gelbke, J., Welzel, H., Skopp, G., & Mann, K. (2009). Decision making of heavy cannabis users on the Iowa Gambling Task: stronger association with THC of hair analysis than with personality traits of the Tridimensional Personality Questionnaire. European Addiction Research, 15(2), 94–98.PubMedCrossRef
Hernandez-Avila, C. A., Rounsaville, B. J., & Kranzler, H. R. (2004). Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug and Alcohol Dependence, 74(3), 265–272.PubMedCrossRef
Hester, R., Nestor, L., & Garavan, H. (2009). Impaired error awareness and anterior cingulate cortex hypoactivity in chronic cannabis users. Neuropsychopharmacology, 34(11), 2450–2458.PubMedCrossRef
Huestegge, L., Kunert, H. J., & Radach, R. (2010). Long-term effects of cannabis on eye movement control in reading. Psychopharmacology, 209(1), 77–84.PubMedCrossRef
Hunault, C. C., Mensinga, T. T., Bocker, K. B., Schipper, C. M., Kruidenier, M., Leenders, M. E., et al. (2009). Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC). Psychopharmacology, 204(1), 85–94.PubMedCrossRef
Indlekofer, F., Piechatzek, M., Daamen, M., Glasmacher, C., Lieb, R., Pfister, H., et al. (2009). Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol. Journal of Psychopharmacology, 23(5), 495–509.PubMedCrossRef
Jacobsen, L. K., Mencl, W. E., Westerveld, M., & Pugh, K. R. (2004). Impact of cannabis use on brain function in adolescents. Annals of the New York Academy of Sciences, 1021, 384–390.PubMedCrossRef
Jacobsen, L. K., Pugh, K. R., Constable, R. T., Westerveld, M., & Mencl, W. E. (2007). Functional correlates of verbal memory deficits emerging during nicotine withdrawal in abstinent adolescent cannabis users. Biological Psychiatry, 61(1), 31–40.PubMedCrossRef
Jacobus, J., McQueeny, T., Bava, S., Schweinsburg, B. C., Frank, L. R., Yang, T. T., et al. (2009). White matter integrity in adolescents with histories of marijuana use and binge drinking. Neurotoxicology and Teratology, 31(6), 349–355.PubMedCrossRef
Jager, G., & Ramsey, N. F. (2008). Long-term consequences of adolescent cannabis exposure on the development of cognition, brain structure and function: an overview of animal and human research. Current Drug Abuse Reviews, 1(2), 114–123.PubMedCrossRef
Jager, G., Kahn, R. S., Van Den Brink, W., Van Ree, J. M., & Ramsey, N. F. (2006). Long-term effects of frequent cannabis use on working memory and attention: an fMRI study. Psychopharmacology, 185(3), 358–368.PubMedCrossRef
Jager, G., Van Hell, H. H., De Win, M. M., Kahn, R. S., Van Den Brink, W., Van Ree, J. M., et al. (2007). Effects of frequent cannabis use on hippocampal activity during an associative memory task. European Neuropsychopharmacology, 17(4), 289–297.PubMedCrossRef
Jager, G., Block, R. I., Luijten, M., & Ramsey, N. F. (2010). Cannabis use and memory brain function in adolescent boys: a cross-sectional multicenter functional magnetic resonance imaging study. Journal of the American Academy of Child and Adolescent Psychiatry, 49(6), 561–572, 572 e561-563.
Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2012). Monitoring the Future national results on adolescent drug use: Overview of key findings, 2011. Ann Arbor: Institute for Social Research, The University of Michigan.
Kalant, H. (2004). Adverse effects of cannabis on health: an update of the literature since 1996. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 28(5), 849–863.CrossRef
King, G. R., Ernst, T., Deng, W., Stenger, A., Gonzales, R. M., Nakama, H., et al. (2011). Altered brain activation during visuomotor integration in chronic active cannabis users: relationship to cortisol levels. Journal of Neuroscience, 31(49), 17923–17931.PubMedCrossRef
Korver, N., Nieman, D. H., Becker, H. E., van de Fliert, J. R., Dingemans, P. H., de Haan, L., et al. (2010). Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls. The Australian and New Zealand Journal of Psychiatry, 44(3), 230–236.PubMedCrossRef
Kramer, J. H., Delis, D. C., & Daniel, M. (1988). Sex-differences in verbal-learning. Journal of Clinical Psychology, 44(6), 907–915.CrossRef
Lane, S. D., Cherek, D. R., Tcheremissine, O. V., Lieving, L. M., & Pietras, C. J. (2005). Acute marijuana effects on human risk taking. Neuropsychopharmacology, 30(4), 800–809.PubMedCrossRef
Lane, S. D., Cherek, D. R., Tcheremissine, O. V., Steinberg, J. L., & Sharon, J. L. (2007). Response perseveration and adaptation in heavy marijuana-smoking adolescents. Addictive Behaviors, 32(5), 977–990.PubMedCrossRef
Lastres-Becker, I., Molina-Holgado, F., Ramos, J. A., Mechoulam, R., & Fernandez-Ruiz, J. (2005). Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson’s disease. Neurobiology of Disease, 19(1–2), 96–107.PubMedCrossRef
Lenroot, R. K., Gogtay, N., Greenstein, D. K., Wells, E. M., Wallace, G. L., Clasen, L. S., et al. (2007). Sexual dimorphism of brain developmental trajectories during childhood and adolescence. NeuroImage, 36(4), 1065–1073.PubMedCrossRef
Li, M. C., Brady, J. E., DiMaggio, C. J., Lusardi, A. R., Tzong, K. Y., & Li, G. (2012). Marijuana use and motor vehicle crashes. Epidemiologic Reviews, 34(1), 65–72.PubMedCrossRef
Looby, A., & Earleywine, M. (2010). Gender moderates the impact of stereotype threat on cognitive function in cannabis users. Addictive Behaviors, 35(9), 834–839.PubMedCrossRef
Lopez, H. H. (2010). Cannabinoid-hormone interactions in the regulation of motivational processes. Hormones and Behavior, 58(1), 100–110.PubMedCrossRef
Mackie, K. (2005). Distribution of cannabinoid receptors in the central and peripheral nervous system. Handbook of Experimental Pharmacology, 168, 299–325.PubMedCrossRef
Mahmood, O. M., Jacobus, J., Bava, S., Scarlett, A., & Tapert, S. F. (2010). Learning and memory performances in adolescent users of alcohol and marijuana: interactive effects. Journal of Studies on Alcohol and Drugs, 71(6), 885–894.PubMed
Makela, P., Wakeley, J., Gijsman, H., Robson, P. J., Bhagwagar, Z., & Rogers, R. D. (2006). Low doses of delta-9 tetrahydrocannabinol (THC) have divergent effects on short-term spatial memory in young, healthy adults. Neuropsychopharmacology, 31(2), 462–470.PubMedCrossRef
Malone, D. T., Hill, M. N., & Rubino, T. (2010). Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models. British Journal of Pharmacology, 160(3), 511–522.PubMedCrossRef
Martin-Santos, R., Fagundo, A. B., Crippa, J. A., Atakan, Z., Bhattacharyya, S., Allen, P., Fusar-Poli, P., Borgwardt, S., Seal, M., Busatto, G. F., & McGuire, P. (2010). Neuroimaging in cannabis use: a systematic review of the literature. Psychological Medicine, 40(3), 383–398.PubMedCrossRef
Martin-Soelch, C., Kobel, M., Stoecklin, M., Michael, T., Weber, S., Krebs, B., et al. (2009). Reduced response to reward in smokers and cannabis users. Neuropsychobiology, 60(2), 94–103.PubMedCrossRef
Mason, B. J., Crean, R., Goodell, V., Light, J. M., Quello, S., Shadan, F., et al. (2012). A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults. Neuropsychopharmacology, 37(7), 1689–1698.PubMedCrossRef
Mateos, B., Borcel, E., Loriga, R., Luesu, W., Bini, V., Llorente, R., et al. (2011). Adolescent exposure to nicotine and/or the cannabinoid agonist CP 55,940 induces gender-dependent long-lasting memory impairments and changes in brain nicotinic and CB(1) cannabinoid receptors. Journal of Psychopharmacology, 25(12), 1676–1690.PubMedCrossRef
McDonald, J., Schleifer, L., Richards, J. B., & de Wit, H. (2003). Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology, 28(7), 1356–1365.PubMedCrossRef
McHale, S., & Hunt, N. (2008). Executive function deficits in short-term abstinent cannabis users. Human Psychopharmacology, 23(5), 409–415.PubMedCrossRef
McQueeny, T., Padula, C. B., Price, J., Medina, K. L., Logan, P., & Tapert, S. F. (2011). Gender effects on amygdala morphometry in adolescent marijuana users. Behavioural Brain Research, 224(1), 128–134.PubMedCrossRef
Mechoulam, R., Spatz, M., & Shohami, E. (2002). Endocannabinoids and neuroprotection. Science Signaling, 2002(129), re5.CrossRef
Mechoulam, R., Peters, M., Murillo-Rodriguez, E., & Hanus, L. O. (2007). Cannabidiol–recent advances. Chemistry & Biodiversity, 4(8), 1678–1692.CrossRef
Medina, K. L., Hanson, K. L., Schweinsburg, A. D., Cohen-Zion, M., Nagel, B. J., & Tapert, S. F. (2007). Neuropsychological functioning in adolescent marijuana users: subtle deficits detectable after a month of abstinence. Journal of the International Neuropsychological Society, 13(5), 807–820.PubMedCrossRef
Medina, K. L., Schweinsburg, A. D., Cohen-Zion, M., Nagel, B. J., & Tapert, S. F. (2007). Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry. Neurotoxicology and Teratology, 29(1), 141–152.PubMedCrossRef
Medina, K. L., McQueeny, T., Nagel, B. J., Hanson, K. L., Yang, T. T., & Tapert, S. F. (2009). Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects. Addiction Biology, 14(4), 457–468.PubMedCrossRef
Moeller, F. G., Barratt, E. S., Dougherty, D. M., Schmitz, J. M., & Swann, A. C. (2001). Psychiatric aspects of impulsivity. The American Journal of Psychiatry, 158(11), 1783–1793.PubMedCrossRef
Montgomery, C., Seddon, A. L., Fisk, J. E., Murphy, P. N., & Jansari, A. (2012). Cannabis-related deficits in real-world memory. Human Psychopharmacology, 27(2), 217–225.PubMedCrossRef
Morgan, C. J., Gardener, C., Schafer, G., Swan, S., Demarchi, C., Freeman, T. P., et al. (2012). Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being. Psychological Medicine, 42(2), 391–400.
Morgan, C. J., Schafer, G., Freeman, T. P., & Curran, H. V. (2010). Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected]. The British Journal of Psychiatry, 197(4), 285–290.PubMedCrossRef
Morrison, P. D., Zois, V., McKeown, D. A., Lee, T. D., Holt, D. W., Powell, J. F., et al. (2009). The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning. Psychological Medicine, 39(10), 1607–1616.PubMedCrossRef
Mura, P., Kintz, P., Ludes, B., Gaulier, J. M., Marquet, P., Martin-Dupont, S., et al. (2003). Comparison of the prevalence of alcohol, cannabis and other drugs between 900 injured drivers and 900 control subjects: results of a French collaborative study. Forensic Science International, 133(1–2), 79–85.PubMedCrossRef
Murphy, L. L., Steger, R. W., Smith, M. S., & Bartke, A. (1990). Effects of delta-9-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combinations, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat. Neuroendocrinology, 52(4), 316–321.PubMedCrossRef
Murphy, L. L., Newton, S. C., Dhali, J., & Chavez, D. (1991). Evidence for a direct anterior pituitary site of delta-9-tetrahydrocannabinol action. Pharmacology Biochemistry and Behavior, 40(3), 603–607.CrossRef
Murphy, L. L., Rodriguez de Fonseca, F., & Steger, R. W. (1991). delta 9-Tetrahydrocannabinol antagonism of the anterior pituitary response to estradiol in immature female rats. Steroids, 56(2), 97–102.PubMedCrossRef
Murphy, L. L., Gher, J., Steger, R. W., & Bartke, A. (1994). Effects of delta 9-tetrahydrocannabinol on copulatory behavior and neuroendocrine responses of male rats to female conspecifics. Pharmacology Biochemistry and Behavior, 48(4), 1011–1017.CrossRef
Murphy, L. L., Adrian, B. A., & Kohli, M. (1999). Inhibition of luteinizing hormone secretion by delta9-tetrahydrocannabinol in the ovariectomized rat: effect of pretreatment with neurotransmitter or neuropeptide receptor antagonists. Steroids, 64(9), 664–671.PubMedCrossRef
Murphy, P. N., Erwin, P. G., Maciver, L., Fisk, J. E., Larkin, D., Wareing, M., et al. (2011). The relationships of ‘ecstasy’ (MDMA) and cannabis use to impaired executive inhibition and access to semantic long-term memory. Human Psychopharmacology, 26(7), 460–469.PubMedCrossRef
Narimatsu, S., Watanabe, K., Yamamoto, I., & Yoshimura, H. (1991). Sex difference in the oxidative metabolism of delta 9-tetrahydrocannabinol in the rat. Biochemical Pharmacology, 41(8), 1187–1194.PubMedCrossRef
Nestor, L., Roberts, G., Garavan, H., & Hester, R. (2008). Deficits in learning and memory: parahippocampal hyperactivity and frontocortical hypoactivity in cannabis users. NeuroImage, 40(3), 1328–1339.PubMedCrossRef
Newman, J. L., & Mello, N. K. (2009). Neuroactive gonadal steroid hormones and drug addiction in women. In K. T. Brady, S. E. Back, & S. F. Greenfield (Eds.), Women and Addiction: A Comprehensive Textbook (pp. 35–64). New York: Guildford Press.
Nixon, S. J., Paul, R., & Phillips, M. (1998). Cognitive efficiency in alcoholics and polysubstance abusers. Alcoholism, Clinical and Experimental Research, 22(7), 1414–1420.PubMedCrossRef
O’Connell, T. J., & Bou-Matar, C. B. (2007). Long term marijuana users seeking medical cannabis in California (2001–2007): demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants. Harm Reduction Journal, 4, 16.PubMedCrossRef
O’Leary, D. S., Block, R. I., Koeppel, J. A., Schultz, S. K., Magnotta, V. A., Ponto, L. B., et al. (2007). Effects of smoking marijuana on focal attention and brain blood flow. Human Psychopharmacology, 22(3), 135–148.PubMedCrossRef
O’Shea, M., Singh, M. E., McGregor, I. S., & Mallet, P. E. (2004). Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. Journal of Psychopharmacology, 18(4), 502–508.PubMedCrossRef
O’Shea, M., McGregor, I. S., & Mallet, P. E. (2006). Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats. Journal of Psychopharmacology, 20(5), 611–621.PubMedCrossRef
Overman, W. H., Frassrand, K., Ansel, S., Trawalter, S., Bies, B., & Redmond, A. (2004). Performance on the IOWA card task by adolescents and adults. Neuropsychologia, 42(13), 1838–1851.PubMedCrossRef
Padula, C. B., Schweinsburg, A. D., & Tapert, S. F. (2007). Spatial working memory performance and fMRI activation interaction in abstinent adolescent marijuana users. Psychology of Addictive Behaviors, 21(4), 478–487.PubMedCrossRef
Perkins, K. A., Levine, M., Marcus, M., Shiffman, S., D’Amico, D., Miller, A., et al. (2000). Tobacco withdrawal in women and menstrual cycle phase. Journal of Consulting and Clinical Psychology, 68(1), 176–180.PubMedCrossRef
Pertwee, R. G. (2008). Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. Addiction Biology, 13(2), 147–159.PubMedCrossRef
Piechatzek, M., Indlekofer, F., Daamen, M., Glasmacher, C., Lieb, R., Pfister, H., et al. (2009). Is moderate substance use associated with altered executive functioning in a population-based sample of young adults? Human Psychopharmacology, 24(8), 650–665.PubMedCrossRef
Pillay, S. S., Rogowska, J., Kanayama, G., Gruber, S., Simpson, N., Pope, H. G., et al. (2008). Cannabis and motor function: fMRI changes following 28 days of discontinuation. Experimental and Clinical Psychopharmacology, 16(1), 22–32.PubMedCrossRef
Piomelli, D. (2003). The molecular logic of endocannabinoid signalling. Nature Reviews Neuroscience, 4(11), 873–884.PubMedCrossRef
Pope, H. G., Jr., Gruber, A. J., & Yurgelun-Todd, D. (1995). The residual neuropsychological effects of cannabis: the current status of research. Drug and Alcohol Dependence, 38(1), 25–34.PubMedCrossRef
Pope, H. G., Jr., Jacobs, A., Mialet, J. P., Yurgelun-Todd, D., & Gruber, S. (1997). Evidence for a sex-specific residual effect of cannabis on visuospatial memory. Psychotherapy and Psychosomatics, 66(4), 179–184.PubMedCrossRef
Pope, H. G., Jr., Gruber, A. J., Hudson, J. I., Cohane, G., Huestis, M. A., & Yurgelun-Todd, D. (2003). Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug and Alcohol Dependence, 69(3), 303–310.PubMedCrossRef
Quinn, H. R., Matsumoto, I., Callaghan, P. D., Long, L. E., Arnold, J. C., Gunasekaran, N., et al. (2008). Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacology, 33(5), 1113–1126.PubMedCrossRef
Ramaekers, J. G., Berghaus, G., van Laar, M., & Drummer, O. H. (2004). Dose related risk of motor vehicle crashes after cannabis use. Drug and Alcohol Dependence, 73(2), 109–119.PubMedCrossRef
Ramaekers, J. G., Kauert, G., Theunissen, E. L., Toennes, S. W., & Moeller, M. R. (2009). Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. Journal of Psychopharmacology, 23(3), 266–277.PubMedCrossRef
Ramaekers, J. G., Theunissen, E. L., de Brouwer, M., Toennes, S. W., Moeller, M. R., & Kauert, G. (2011). Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users. Psychopharmacology, 214(2), 391–401.PubMedCrossRef
Ranganathan, M., & D’Souza, D. C. (2006). The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology, 188(4), 425–444.PubMedCrossRef
Realini, N., Rubino, T., & Parolaro, D. (2009). Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids. Pharmacological Research, 60(2), 132–138.PubMedCrossRef
Reavis, R., & Overman, W. H. (2001). Adult sex differences on a decision-making task previously shown to depend on the orbital prefrontal cortex. Behavioral Neuroscience, 115(1), 196–206.PubMedCrossRef
Reich, C. G., Taylor, M. E., & McCarthy, M. M. (2009). Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats. Behavioural Brain Research, 203(2), 264–269.PubMedCrossRef
Roberts, G. M., & Garavan, H. (2010). Evidence of increased activation underlying cognitive control in ecstasy and cannabis users. NeuroImage, 52(2), 429–435.PubMedCrossRef
Rodriguez de Fonseca, F., Cebeira, M., Ramos, J. A., Martin, M., & Fernandez-Ruiz, J. J. (1994). Cannabinoid receptors in rat brain areas: sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement. Life Sciences, 54(3), 159–170.PubMedCrossRef
Rogers, R. D., Wakeley, J., Robson, P. J., Bhagwagar, Z., & Makela, P. (2007). The effects of low doses of delta-9 tetrahydrocannabinol on reinforcement processing in the risky decision-making of young healthy adults. Neuropsychopharmacology, 32(2), 417–428.PubMedCrossRef
Roser, P., Gallinat, J., Weinberg, G., Juckel, G., Gorynia, I., & Stadelmann, A. M. (2009). Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects. European Archives of Psychiatry and Clinical Neuroscience, 259(5), 284–292.PubMedCrossRef
Rubino, T., Vigano, D., Realini, N., Guidali, C., Braida, D., Capurro, V., et al. (2008). Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. Neuropsychopharmacology, 33(11), 2760–2771.PubMedCrossRef
Rubino, T., Realini, N., Braida, D., Alberio, T., Capurro, V., Vigano, D., et al. (2009). The depressive phenotype induced in adult female rats by adolescent exposure to THC is associated with cognitive impairment and altered neuroplasticity in the prefrontal cortex. Neurotoxicity Research, 15(4), 291–302.PubMedCrossRef
Rubino, T., Realini, N., Braida, D., Guidi, S., Capurro, V., Vigano, D., et al. (2009). Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood. Hippocampus, 19(8), 763–772.PubMedCrossRef
SAMSHA. (2011). Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings, NSDUH. Rockville: Substance Abuse and Mental Health Services Administration.
Schepis, T. S., Desai, R. A., Smith, A. E., Cavallo, D. A., Liss, T. B., McFetridge, A., et al. (2008). Impulsive sensation seeking, parental history of alcohol problems, and current alcohol and tobacco use in adolescents. Journal of Addiction Medicine, 2(4), 185–193.PubMedCrossRef
Scholes, K. E., & Martin-Iverson, M. T. (2009). Alterations to pre-pulse inhibition (PPI) in chronic cannabis users are secondary to sustained attention deficits. Psychopharmacology, 207(3), 469–484.PubMedCrossRef
Scholes, K. E., & Martin-Iverson, M. T. (2010). Cannabis use and neuropsychological performance in healthy individuals and patients with schizophrenia. Psychological Medicine, 40(10), 1635–1646.PubMedCrossRef
Scholes-Balog, K. E., & Martin-Iverson, M. T. (2011). Cannabis use and sensorimotor gating in patients with schizophrenia and healthy controls. Human Psychopharmacology, 26(3), 373–385.
Schuster, R. M., Crane, N. A., Mermelstein, R., & Gonzalez, R. (2012). The influence of inhibitory control and episodic memory on the risky sexual behavior of young adult cannabis users. Journal of the International Neuropsychological Society, 18(5), 827–833.PubMedCrossRef
Schweinsburg, A. D., Brown, S. A., & Tapert, S. F. (2008). The influence of marijuana use on neurocognitive functioning in adolescents. Current Drug Abuse Reviews, 1(1), 99–111.PubMedCrossRef
Schweinsburg, A. D., Schweinsburg, B. C., Medina, K. L., McQueeny, T., Brown, S. A., & Tapert, S. F. (2010). The influence of recency of use on fMRI response during spatial working memory in adolescent marijuana users. Journal of Psychoactive Drugs, 42(3), 401–412.PubMedCrossRef
Schweinsburg, A. D., Schweinsburg, B. C., Nagel, B. J., Eyler, L. T., & Tapert, S. F. (2011). Neural correlates of verbal learning in adolescent alcohol and marijuana users. Addiction, 106(3), 564–573.PubMedCrossRef
Scorticati, C., Mohn, C., De Laurentiis, A., Vissio, P., Fernandez Solari, J., Seilicovich, A., et al. (2003). The effect of anandamide on prolactin secretion is modulated by estrogen. Proceedings of the National Academy of Sciences of the United States of America, 100(4), 2134–2139.PubMedCrossRef
Scorticati, C., Fernandez-Solari, J., De Laurentiis, A., Mohn, C., Prestifilippo, J. P., Lasaga, M., et al. (2004). The inhibitory effect of anandamide on luteinizing hormone-releasing hormone secretion is reversed by estrogen. Proceedings of the National Academy of Sciences of the United States of America, 101(32), 11891–11896.PubMedCrossRef
Sofuoglu, M., Dudish-Poulsen, S., Nelson, D., Pentel, P. R., & Hatsukami, D. K. (1999). Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans. Experimental and Clinical Psychopharmacology, 7(3), 274–283.PubMedCrossRef
Solowij, N., & Battisti, R. (2008). The chronic effects of cannabis on memory in humans: a review. Current Drug Abuse Reviews, 1(1), 81–98.PubMedCrossRef
Solowij, N., & Pesa, N. (2010). Cognitive abnormalities and cannabis use. Revista Brasileira de Psiquiatria, 32(Suppl 1), S31–S40.PubMed
Solowij, N., Jones, K. A., Rozman, M. E., Davis, S. M., Ciarrochi, J., Heaven, P. C., et al. (2011). Verbal learning and memory in adolescent cannabis users, alcohol users and non-users. Psychopharmacology, 216(1), 131–144.PubMedCrossRef
Solowij, N., Jones, K. A., Rozman, M. E., Davis, S. M., Ciarrochi, J., Heaven, P. C., et al. (2012). Reflection impulsivity in adolescent cannabis users: a comparison with alcohol-using and non-substance-using adolescents. Psychopharmacology, 219(2), 575–586.PubMedCrossRef
Steger, R. W., Silverman, A. Y., Siler-Khodr, T. M., & Asch, R. H. (1980). The effects of delta 9-tetrahydrocannabinol on the positive and negative feedback control of luteinizing hormone release. Life Sciences, 27(20), 1911–1916.PubMedCrossRef
Steger, R. W., DePaolo, L., Asch, R. H., & Silverman, A. Y. (1983). Interactions of delta 9-tetrahydrocannabinol (THC) with hypothalamic neurotransmitters controlling luteinizing hormone and prolactin release. Neuroendocrinology, 37(5), 361–370.PubMedCrossRef
Sugarman, D. E., Poling, J., & Sofuoglu, M. (2011). The safety of modafinil in combination with oral 9-tetrahydrocannabinol in humans. Pharmacology, Biochemistry, and Behavior, 98(1), 94–100.PubMedCrossRef
Tait, R. J., Mackinnon, A., & Christensen, H. (2011). Cannabis use and cognitive function: 8-year trajectory in a young adult cohort. Addiction, 106(12), 2195–2203.PubMedCrossRef
Tapert, S. F., Schweinsburg, A. D., Drummond, S. P., Paulus, M. P., Brown, S. A., Yang, T. T., et al. (2007). Functional MRI of inhibitory processing in abstinent adolescent marijuana users. Psychopharmacology, 194(2), 173–183.PubMedCrossRef
Theunissen, E. L., Kauert, G. F., Toennes, S. W., Moeller, M. R., Sambeth, A., Blanchard, M. M., et al. (2011). Neurophysiological functioning of occasional and heavy cannabis users during THC intoxication. Psychopharmacology, 220(2), 341–350.CrossRef
Tulving, E. (2001). Episodic memory and common sense: how far apart? Philosophical Transactions of the Royal Society of London, 356(1413), 1505–1515.PubMedCrossRef
United Nations Office on Drugs and Crimes. (2011). World Drug Report, United Nations Publications, Sales No. E.11.XI.10.
Vadhan, N. P., Hart, C. L., van Gorp, W. G., Gunderson, E. W., Haney, M., & Foltin, R. W. (2007). Acute effects of smoked marijuana on decision making, as assessed by a modified gambling task, in experienced marijuana users. Journal of Clinical and Experimental Neuropsychology, 29(4), 357–364.PubMedCrossRef
Vaidya, J. G., Block, R. I., O’Leary, D. S., Ponto, L. B., Ghoneim, M. M., & Bechara, A. (2012). Effects of chronic marijuana use on brain activity during monetary decision-making. Neuropsychopharmacology, 37(3), 618–629.PubMedCrossRef
Van Laere, K., Goffin, K., Casteels, C., Dupont, P., Mortelmans, L., de Hoon, J., et al. (2008). Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET. NeuroImage, 39(4), 1533–1541.PubMedCrossRef
Viveros, M. P., Llorente, R., Suarez, J., Llorente-Berzal, A., Lopez-Gallardo, M., & Rodriguez de Fonseca, F. (2012). The endocannabinoid system in critical neurodevelopmental periods: sex differences and neuropsychiatric implications. Journal of Psychopharmacology, 26(1), 164–176.PubMedCrossRef
Wadsworth, E. J., Moss, S. C., Simpson, S. A., & Smith, A. P. (2006). Cannabis use, cognitive performance and mood in a sample of workers. Journal of Psychopharmacology, 20(1), 14–23.PubMedCrossRef
Wagner, D., Becker, B., Gouzoulis-Mayfrank, E., & Daumann, J. (2010). Interactions between specific parameters of cannabis use and verbal memory. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 34(6), 871–876.CrossRef
Ware, M. A., Adams, H., & Guy, G. W. (2005). The medicinal use of cannabis in the UK: results of a nationwide survey. International Journal of Clinical Practice, 59(3), 291–295.PubMedCrossRef
Watson, S. J., Benson, J. A., Jr., & Joy, J. E. (2000). Marijuana and medicine: assessing the science base: a summary of the 1999 Institute of Medicine report. Archives of General Psychiatry, 57(6), 547–552.PubMedCrossRef
Weinstein, A., Brickner, O., Lerman, H., Greemland, M., Bloch, M., Lester, H., et al. (2008a). Brain imaging study of the acute effects of Delta9-tetrahydrocannabinol (THC) on attention and motor coordination in regular users of marijuana. Psychopharmacology, 196(1), 119–131.PubMedCrossRef
Weinstein, A., Brickner, O., Lerman, H., Greemland, M., Bloch, M., Lester, H., et al. (2008b). A study investigating the acute dose–response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana. Journal of Psychopharmacology, 22(4), 441–451.PubMedCrossRef
Weller, J. A., Levin, I. P., & Bechara, A. (2010). Do individual differences in Iowa Gambling Task performance predict adaptive decision making for risky gains and losses? Journal of Clinical and Experimental Neuropsychology, 32(2), 141–150.PubMedCrossRef
Wenger, T., Fernandez-Ruiz, J. J., & Ramos, J. A. (1999). Immunocytochemical demonstration of CB1 cannabinoid receptors in the anterior lobe of the pituitary gland. Journal of Neuroendocrinology, 11(11), 873–878.PubMedCrossRef
Wert, R. C., & Raulin, M. L. (1986). The chronic cerebral effects of cannabis use. II. Psychological findings and conclusions. The International Journal of the Addictions, 21(6), 629–642.PubMed
Wesley, M. J., Hanlon, C. A., & Porrino, L. J. (2011). Poor decision-making by chronic marijuana users is associated with decreased functional responsiveness to negative consequences. Psychiatry Research, 191(1), 51–59.PubMedCrossRef
Winton-Brown, T. T., Allen, P., Bhattacharyya, S., Borgwardt, S. J., Fusar-Poli, P., Crippa, J. A., et al. (2011). Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study. Neuropsychopharmacology, 36(7), 1340–1348.PubMedCrossRef
Yucel, M., Solowij, N., Respondek, C., Whittle, S., Fornito, A., Pantelis, C., et al. (2008). Regional brain abnormalities associated with long-term heavy cannabis use. Archives of General Psychiatry, 65(6), 694–701.PubMedCrossRef
Metadata
Title
Effects of Cannabis on Neurocognitive Functioning: Recent Advances, Neurodevelopmental Influences, and Sex Differences
Authors
Natania A. Crane
Randi Melissa Schuster
Paolo Fusar-Poli
Raul Gonzalez
Publication date
01-06-2013
Publisher
Springer US
Published in
Neuropsychology Review / Issue 2/2013
Print ISSN: 1040-7308
Electronic ISSN: 1573-6660
DOI
https://doi.org/10.1007/s11065-012-9222-1

Other articles of this Issue 2/2013

Neuropsychology Review 2/2013 Go to the issue

Review

Is the Right Anterior Temporal Variant of Prosopagnosia a Form of ‘Associative Prosopagnosia’ or a Form of ‘Multimodal Person Recognition Disorder’?

Review

What is Overt and what is Covert in Congenital Prosopagnosia?

Review

Autobiographical Memory, Self, and Stress-Related Psychiatric Disorders: Which Implications in Cancer Patients?

Review

Systematic Review: Are Overweight and Obese Individuals Impaired on Behavioural Tasks of Executive Functioning?